William P. Sheridan is CMO & VP at BIOCRYST PHARMACEUTICALS INC (BCRX). They have made 10 open-market trades across 1 company since 2009, most recently 2022-03-10.
CIK 0001439174
1 open-market purchase totalling $5K since 2009, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCRX | 37,954 | $295K |
Shares reported on the most recent Form 4, priced at the 2022-03-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCRX | SELL | 2022-03-10 | 2022-03-14 | $16.87 | $5.4M | +4.8% | -20.9% | -41.3% |
| BCRX | SELL | 2021-05-27 | 2021-06-01 | $15.01 | $3.8M | +4.4% | +1.7% | -1.9% |
| BCRX | SELL | 2021-02-22 | 2021-02-24 | $11.57 | $955K | +0.0% | -6.7% | +19.7% |
| BCRX | SELL | 2018-12-18 | 2018-12-20 | $7.58 | $311K | +14.9% | +25.6% | +7.5% |
| BCRX | SELL | 2018-08-09 | 2018-08-13 | $7.03 | $439K | +1.3% | -1.1% | +0.3% |
| BCRX | SELL | 2018-06-01 | 2018-06-05 | $6.30 | $531K | -7.0% | -5.7% | +23.2% |
| BCRX | SELL | 2017-11-13 | 2017-11-15 | $4.72 | $607K | +3.7% | +8.7% | +8.5% |
| BCRX | SELL · 10b5-1 | 2015-06-19 | 2015-06-22 | $15.05 | $1.1M | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2014-12-29 | 2014-12-31 | $12.36 | $1.6M | -26.4% | -2.7% | -2.7% |
| BCRX | SELL | 2012-03-02 | 2012-03-05 | $4.78 | $5K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2010-04-08 | 2010-04-12 | $8.01 | $149K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2010-01-11 | 2010-01-12 | $8.05 | $34K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2009-12-01 | 2009-12-02 | $8.17 | $34K | -26.4% | -2.7% | -2.7% |
| BCRX | SELL · 10b5-1 | 2009-10-14 | 2009-10-15 | $8.92 | $54K | -26.4% | -2.7% | -2.7% |
| BCRX | BUY | 2009-01-30 | 2009-02-03 | $1.62 | $5K | -26.4% | -2.7% | -2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.